TALIGEN THERAPEUTICS
Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases. The company's lead therapeutic candidates are monoclonal antibodies and recombinant fusion proteins that target key factors in the alternative pathway, which Taligen's founders have validated as an important amplification loop in the inflammation process.
TALIGEN THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.taligentherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
617-444-8443
Email Addresses:
[email protected]
Total Funding:
78.75 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Current Employees Featured
Founder
Investors List
Alta Partners
Alta Partners investment in Series B - Taligen Therapeutics
Sanderling Ventures
Sanderling Ventures investment in Series B - Taligen Therapeutics
Clarus Ventures
Clarus Ventures investment in Series B - Taligen Therapeutics
High Country Venture
High Country Venture investment in Series B - Taligen Therapeutics
Alta Partners
Alta Partners investment in Series B - Taligen Therapeutics
Clarus Ventures
Clarus Ventures investment in Series B - Taligen Therapeutics
High Country Venture
High Country Venture investment in Series B - Taligen Therapeutics
Sanderling Ventures
Sanderling Ventures investment in Series B - Taligen Therapeutics
University License Equity Holdings
University License Equity Holdings investment in Series A - Taligen Therapeutics
High Country Venture
High Country Venture investment in Series A - Taligen Therapeutics
Official Site Inspections
http://www.taligentherapeutics.com
Unable to get host informations!!!
